Summary
For Year 2026-27, JFL Life Sciences reports the following shareholding: Total Promoters at 67.47%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0%, Domestic Institutional Investors at 0%, and Retail at 32.53%. This breakdown provides a quick snapshot of ownership distribution for JFL Life Sciences in 2026-27.
JFL Life Sciences FAQs
As of 04-2026, the promoter shareholding in JFL Life Sciences stands at 67.47% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of JFL Life Sciences is 0% and 0% respectively.
The retail shareholding of the JFL Life Sciences is 32.53%.
Changes in shareholding patterns of JFL Life Sciences can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of JFL Life Sciences are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
JFL Life Sciences Associated Pages
